The conference will bring together leaders from a multitude of scientific disciplines to show case unpublished data, new therapeutic advances and translational case studies to highlight not only the potential applications for microbiome research, but also the challenges surrounding clinical implementation. Microbiome research is set to revolutionise not only disease therapeutics, but also diagnostics and preventative medicine and therefore, it is more important than ever to provide a platform for education, collaboration and discussion.
The Arrowhead Translational Microbiome Conference continues to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products.
Oxford Global is proud to present the inaugural Microbiome Discovery and Development Congress on the 12 – 13 June 2017 in Berlin, Germany. This congress will bring together key opinion leaders and senior industry experts in microbiome drug discovery to discuss the latest innovative discovery strategies and technologies, the commercialization of the microbiome and the therapeutic potential. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Senior Directors and Professors from global pharmaceutical organizations, biotech companies and leading research institutions.
Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future.